FibroGen, Inc.
CRYSTALLINE FORMS OF A PROLYL HYDROXYLASE INHIBITOR
Last updated:
Abstract:
The present disclosure relates to crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid, the process of preparing the forms, and pharmaceutical compositions and methods of use thereof.
Status:
Application
Type:
Utility
Filling date:
11 Oct 2018
Issue date:
12 Sep 2019